Reference X12 Release 7060 Elements 1815 Controlled Drug
1815 Controlled DrugControlled Drug is a product from Schedule 3, 4 or 5 of the CDSA excluding those substances listed in Schedule 1 of the Benzodiazepine and Other Targeted Substances regulations. Type Identifier (ID) Length Min 4 / Max 4 Codes Code Description Part G Schedule - Part I Part G Schedule - Part II Part G Schedule - Part III Not Applicable
Stedi is a registered trademark of Stedi, Inc. Stedi's EDI Reference
is provided for marketing purposes and is free of
charge. All names, logos, and brands of third parties listed on our site
are trademarks of their respective owners (including “X12”, which is a
trademark of X12 Incorporated). Stedi, Inc. and its products and services
are not endorsed by, sponsored by, or affiliated with these third parties.
Our use of these names, logos, and brands is for identification purposes
only, and does not imply any such endorsement, sponsorship, or
affiliation.
Stedi is a registered trademark of Stedi, Inc. Stedi's EDI Reference
is provided for marketing purposes and is free of
charge. All names, logos, and brands of third parties listed on our site
are trademarks of their respective owners (including “X12”, which is a
trademark of X12 Incorporated). Stedi, Inc. and its products and services
are not endorsed by, sponsored by, or affiliated with these third parties.
Our use of these names, logos, and brands is for identification purposes
only, and does not imply any such endorsement, sponsorship, or
affiliation.